Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRAF mutation screening in melanoma: is sentinel lymph node reliable?

Melanoma research - 1 Aug 2015

Nardin Charlée, Puzenat Eve, Prétet Jean Luc, Algros Marie Paule, Doussot Alexandre, Puyraveau Marc, Mougin Christiane, Aubin François

Abstract excerpt

As the detection of the BRAF V600E mutation has a direct impact on treatment decision, an accurate screening for BRAF mutations in patients with advanced or metastatic melanoma is mandatory. Nevertheless, BRAF oncogene mutation status between different samples from the same patient has been studied with conflicting results. This study investigated the intrapatient homogeneity of BRAF mutation status using...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to DNA Mutational Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Lymphatic Metastasis

Share to Melanoma

Share to Proto-Oncogene Proteins B-raf

Share to Skin Neoplasms

Share to Young Adult

Source

Identifiers

PMID: 26020488
DOI: 10.1097/CMR.0000000000000166

Genes

BRAF
SLN

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRAF mutation screening in melanoma: is sentinel lymph node reliable?PMID 26020488Read ↗

Lymph node metastases of melanoma: challenges for BRAF mutation detection.Semantic proximity Read ↗

Investigation of BRAF mutation analysis with different technical platforms in metastatic melanoma.Semantic proximity Read ↗

Heterogeneity and frequency of BRAF mutations in primary melanoma: Comparison between molecular methods and immunohistochemistry.Semantic proximity Read ↗

Prognostic value of BRAF(V⁶⁰⁰) mutations in melanoma patients after resection of metastatic lymph nodes.Semantic proximity Read ↗

Rare BRAF mutations in melanoma patients: implications for molecular testing in clinical practice.Semantic proximity Read ↗

Mutation landscape in melanoma patients clinical implications of heterogeneity of BRAF mutationsSemantic proximity Read ↗

BRAF Heterogeneity in Melanoma.Semantic proximity Read ↗

Comparison between two widely used laboratory methods in BRAF V600 mutation detection in a large cohort of clinical samples of cutaneous melanoma metastases to the lymph nodes.Semantic proximity Read ↗

Tumor homogeneity between primary and metastatic sites for BRAF status in metastatic melanoma determined by immunohistochemical and molecular testing.Semantic proximity Read ↗

NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing.Semantic proximity Read ↗

Clinical and therapeutic implications of BRAF mutation heterogeneity in metastatic melanoma.Semantic proximity Read ↗

Intra-patient Heterogeneity of BRAF and NRAS Molecular Alterations in Primary Melanoma and Metastases.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.